Skip to content

BioCentury Emerging Company Profile: PrecisionLife

U.K. company untangling genomic interactions to find targets in complex diseases

BioCentury AI Drug Discovery company profile PrecisionLife

PrecisionLife: learning from genetic interactions by cutting noise

BioCentury, 2 February 2023  -  Having pivoted from providing software to delivering target and biomarker insights via its 2019 reboot, PrecisionLife is untangling the biological networks behind complex diseases using a dimensionality reduction approach borrowed from other industries.


Read the article in BioCentury

Sign Up

Subscribe to our newsletter